Business

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

CRISPR-Focused Companies Take Stock Dive

Shares in various companies using gene editing technologies fell earlier this week, after it was widely reported that CRISPR may raise the risk of cancer in edited cell populations.